2019 annual financial data
AN2 Therapeutics 2019 Operating margin
AN2 Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -31,068,000 USD and net income was -33,810,000 USD.
Operating cash flow was -2,486,000 USD.
Get free AN2 Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -31,068,000 USD
- Net income
- -33,810,000 USD
- Operating cash flow
- -2,486,000 USD